Detailed TOC of Global PROTAC Drug Market Research Report 2032
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PROTAC Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Based on CRBN
1.2.3 Based on VHL
1.3 Market by Application
1.3.1 Global PROTAC Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PROTAC Drug Market Perspective (2019-2030)
2.2 PROTAC Drug Growth Trends by Region
2.2.1 Global PROTAC Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PROTAC Drug Historic Market Size by Region (2019-2032)
2.2.3 PROTAC Drug Forecasted Market Size by Region (2025-2030)
2.3 PROTAC Drug Market Dynamics
2.3.1 PROTAC Drug Industry Trends
2.3.2 PROTAC Drug Market Drivers
2.3.3 PROTAC Drug Market Challenges
2.3.4 PROTAC Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PROTAC Drug Players by Revenue
3.1.1 Global Top PROTAC Drug Players by Revenue (2019-2032)
3.1.2 Global PROTAC Drug Revenue Market Share by Players (2019-2032)
3.2 Global PROTAC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PROTAC Drug Revenue
3.4 Global PROTAC Drug Market Concentration Ratio
3.4.1 Global PROTAC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PROTAC Drug Revenue in 2023
3.5 PROTAC Drug Key Players Head office and Area Served
3.6 Key Players PROTAC Drug Product Solution and Service
3.7 Date of Enter into PROTAC Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PROTAC Drug Breakdown Data by Type
4.1 Global PROTAC Drug Historic Market Size by Type (2019-2032)
4.2 Global PROTAC Drug Forecasted Market Size by Type (2025-2030)
5 PROTAC Drug Breakdown Data by Application
5.1 Global PROTAC Drug Historic Market Size by Application (2019-2032)
5.2 Global PROTAC Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PROTAC Drug Market Size (2019-2030)
6.2 North America PROTAC Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America PROTAC Drug Market Size by Country (2019-2032)
6.4 North America PROTAC Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PROTAC Drug Market Size (2019-2030)
7.2 Europe PROTAC Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe PROTAC Drug Market Size by Country (2019-2032)
7.4 Europe PROTAC Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PROTAC Drug Market Size (2019-2030)
8.2 Asia-Pacific PROTAC Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific PROTAC Drug Market Size by Region (2019-2032)
8.4 Asia-Pacific PROTAC Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PROTAC Drug Market Size (2019-2030)
9.2 Latin America PROTAC Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America PROTAC Drug Market Size by Country (2019-2032)
9.4 Latin America PROTAC Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PROTAC Drug Market Size (2019-2030)
10.2 Middle East & Africa PROTAC Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa PROTAC Drug Market Size by Country (2019-2032)
10.4 Middle East & Africa PROTAC Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Detail
11.1.2 Arvinas Business Overview
11.1.3 Arvinas PROTAC Drug Introduction
11.1.4 Arvinas Revenue in PROTAC Drug Business (2019-2032)
11.1.5 Arvinas Recent Development
11.2 Nurix
11.2.1 Nurix Company Detail
11.2.2 Nurix Business Overview
11.2.3 Nurix PROTAC Drug Introduction
11.2.4 Nurix Revenue in PROTAC Drug Business (2019-2032)
11.2.5 Nurix Recent Development
11.3 Kymera Therapeutics
11.3.1 Kymera Therapeutics Company Detail
11.3.2 Kymera Therapeutics Business Overview
11.3.3 Kymera Therapeutics PROTAC Drug Introduction
11.3.4 Kymera Therapeutics Revenue in PROTAC Drug Business (2019-2032)
11.3.5 Kymera Therapeutics Recent Development
11.4 C4 Therapeutics
11.4.1 C4 Therapeutics Company Detail
11.4.2 C4 Therapeutics Business Overview
11.4.3 C4 Therapeutics PROTAC Drug Introduction
11.4.4 C4 Therapeutics Revenue in PROTAC Drug Business (2019-2032)
11.4.5 C4 Therapeutics Recent Development
11.5 Ranok Therapeutics
11.5.1 Ranok Therapeutics Company Detail
11.5.2 Ranok Therapeutics Business Overview
11.5.3 Ranok Therapeutics PROTAC Drug Introduction
11.5.4 Ranok Therapeutics Revenue in PROTAC Drug Business (2019-2032)
11.5.5 Ranok Therapeutics Recent Development
11.6 Accutar Biotechnology
11.6.1 Accutar Biotechnology Company Detail
11.6.2 Accutar Biotechnology Business Overview
11.6.3 Accutar Biotechnology PROTAC Drug Introduction
11.6.4 Accutar Biotechnology Revenue in PROTAC Drug Business (2019-2032)
11.6.5 Accutar Biotechnology Recent Development
11.7 BeiGene Ltd.
11.7.1 BeiGene Ltd. Company Detail
11.7.2 BeiGene Ltd. Business Overview
11.7.3 BeiGene Ltd. PROTAC Drug Introduction
11.7.4 BeiGene Ltd. Revenue in PROTAC Drug Business (2019-2032)
11.7.5 BeiGene Ltd. Recent Development
11.8 Hinova Pharmaceuticals
11.8.1 Hinova Pharmaceuticals Company Detail
11.8.2 Hinova Pharmaceuticals Business Overview
11.8.3 Hinova Pharmaceuticals PROTAC Drug Introduction
11.8.4 Hinova Pharmaceuticals Revenue in PROTAC Drug Business (2019-2032)
11.8.5 Hinova Pharmaceuticals Recent Development
11.9 Haisco Pharmaceutical
11.9.1 Haisco Pharmaceutical Company Detail
11.9.2 Haisco Pharmaceutical Business Overview
11.9.3 Haisco Pharmaceutical PROTAC Drug Introduction
11.9.4 Haisco Pharmaceutical Revenue in PROTAC Drug Business (2019-2032)
11.9.5 Haisco Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
